|
ZNF785 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.219800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.060300E-03 |
| Normal-vs-Stage2 |
8.732400E-02 |
| Normal-vs-Stage3 |
7.72690000000464E-05 |
| Normal-vs-Stage4 |
3.225500E-04 |
| Stage1-vs-Stage2 |
6.147200E-01 |
| Stage1-vs-Stage3 |
4.376300E-02 |
| Stage1-vs-Stage4 |
5.392200E-02 |
| Stage2-vs-Stage3 |
6.439700E-02 |
| Stage2-vs-Stage4 |
8.020300E-02 |
| Stage3-vs-Stage4 |
9.384000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.239660E-04 |
| Normal-vs-AfricanAmerican |
2.511400E-01 |
| Normal-vs-Asian |
3.009600E-01 |
| Caucasian-vs-AfricanAmerican |
1.884820E-01 |
| Caucasian-vs-Asian |
2.052200E-02 |
| AfricanAmerican-vs-Asian |
7.238600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.917000E-03 |
| Normal-vs-Female |
2.424900E-04 |
| Male-vs-Female |
6.320400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.781300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.300000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.239200E-04 |
| Normal-vs-Age(81-100Yrs) |
6.028200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.909400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.788800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.971000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.763170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.007800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.938400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.17340000049815E-07 |
| Classical-VS-Follicular |
6.914400E-01 |
| Classical-VS-Other |
9.122600E-01 |
| Classical-VS-Normal |
1.137770E-02 |
| Tall-VS-Follicular |
1.954030E-04 |
| Tall-VS-Other |
3.128200E-01 |
| Tall-VS-Normal |
4.96299999985794E-08 |
| Follicular-VS-Other |
9.840400E-01 |
| Follicular-VS-Normal |
1.510300E-02 |
| Other-VS-Normal |
2.794800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.859300E-03 |
| Normal-vs-N1 |
4.424900E-04 |
| N0-vs-N1 |
8.243500E-02 |
|
|
